Changing Epidemiology of Invasive Mold Infections in Patients Receiving Azole Prophylaxis.
Published
Journal Article
Breakthrough invasive mold infections (IMIs) that occur during posaconazole or voriconazole prophylaxis are rare complications for which epidemiological data are lacking. This retrospective analysis comparing 24 microbiologically documented breakthrough with 66 nonbreakthrough IMIs shows a shift towards non-Aspergillus molds with a significantly increased proportion of rare multidrug-resistant molds.
Full Text
Duke Authors
Cited Authors
- Lamoth, F; Chung, SJ; Damonti, L; Alexander, BD
Published Date
- June 1, 2017
Published In
- Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
Volume / Issue
- 64 / 11
Start / End Page
- 1619 - 1621
PubMed ID
- 28199491
Pubmed Central ID
- 28199491
Electronic International Standard Serial Number (EISSN)
- 1537-6591
Digital Object Identifier (DOI)
- 10.1093/cid/cix130
Language
- eng
Conference Location
- United States